BRIEF-FDA's Woodcock Says Will Review Pfizer's Request To Amend EUA To Expand Age Range For Its COVID19 Vaccine To Include Indi
BRIEF-FDA's Woodcock Says Will Review Pfizer's Request To Amend EUA To Expand Age Range For Its COVID19 Vaccine To Include Indi
Brief-FDA的Woodcock表示,將審查輝瑞修改EUA的請求,以擴大其COVID19疫苗的年齡範圍,將INDI包括在內
April 9 (Reuters) -
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
April 9 (Reuters) -
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透4月9日電-*FDA的Woodcock-將審查輝瑞修改EUA的請求,以擴大其COVID19疫苗的年齡範圍,將12-15歲的個人包括在內-推特源文本:進一步的公司報道:(Reurs.Briefs@thomsonreurs.com;)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
搶先評論
0 0 0
讚好勁正笑哭社會社會Emm惨惨嬲嬲
輕觸選擇心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧
點擊這裡與好友分享
暫無評論,快來留言吧!